Trial
NCT06011577
Randomized, Double-Blind, Placebo-Controlled Trial of REL-1017 as Adjunctive Treatment for MDD
Phase IIITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Levomecor Inc.
Collaborators
—
Condition
Major Depressive Disorder
Intervention
REL-1017
Why stopped
Program Discontinued
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-11-06